Skyscape Web Viewer : CURRENT Practice Guidelines In Primary Care : Table Index

View All
Table 25-10 First-Line Therapy For ITP
Table 25-1 Common Causes of Anemia
Table 25-3 Infectious Complications of Transfusion
Table 25-5 Wells Score For Pe
Table 25-7 Recommended Anticoagulant Selection and Duration of Anticoagulation For Pulmonary Embolism Based On Risk Factors and Location of Pulmonary Embolism
Table 25-9 Diagnostic Tool For Diagnosis of HIT
Table 26-2 Medical Conditions That Increase Risk of Progression to Severe COVID
Table 26-4 Sexually Transmitted Diseases Treatment Guidelines
Table 2-7 Risk Factors For Bleeding (Chest. 2011;139:69-79)
Table 28-4 Example of Serious Medical Conditions That Might Warrant Consideration of Further Evalution and Therapy in Hospital Setting
Table 29-1 Cdc Medical Eligibility Criteria for Contraceptive Use
Table 29-3 Extended Use of Long-Acting Reversible Contraception
Table 29-6 Aap and Afp Perinatal and Postnatal Guidelines
Table 2 Recommended Catch-Up Immunization Schedule For Children and Adolescents Who Start Late or Who Are More Than 1 Month Behind, United States, 2023
Table 30-2 Step Therapy in Asthma Management, Ages 6-11
Table 32-1 Treatment Options For Acne
Table 4 Recommended Adult Immunization Schedule For Ages 19 Y or Older, United States, 2023
Table 5-2 Screening in High-Incidence Settings Stratified by Resource Availability
Table 2-2 Statin Intensity Drug Levels
Table 2-3 Statin-Associated Side Effects
Table 24-2 Responses to Abnormal Screening Results, Patients Age 25-65 with Prior Anomaliesa
Table 24-4 Risk-Stratified Evaluation of Microscopic Hematuria
Table 24-6 Clinical Diagnosis of Vaginitis
Table 25-11 Selected Second-Line Therapy Options in Adult ITP
Table 25-2 Noninfectious Complications of Blood Transfusion
Table 25-4 Wells Score For DVT
Table 25-6 Recommended Anticoagulant Selection and Duration of Anticoagulation Based On Risk Factors and Location of DVT
Table 25-8 New Oral Anticoagulantsa and Warfarin
Table 26-1 Cdc Patient Risk Groups For Prioritizing COVID Therapy
Table 26-3 Comparison of Recommendations For Various Therapies in Nonsevere Disease, in the Non-Hospital Setting